Central Europe is one of the main R&D centre of biotechnology in the world. Labs from Poland, Czech, Estonia and Hungary are present a high business potential and science potential projects every month. BioForum 2011 is attracting investors from the whole world and as a result of innovations projects it’s a strategic event for them. 10th anniversary edition of BioForum 2011 owing of organizer will start a historical agreement between biotechnology centers of Central Europe and Asia.
BioForum was a whitness of creating strongly business and science partnership many times. Creation of Mabion from agreement of four biotechnology companies: Celon Pharma Sp.z o.o., Polfarmex S.A., Genexo Sp. z o.o. and IBSS Biomed S.A. and consulting companies: Bio-Tech Consulting and BioCentrum is a perfect ex ample for that. Mabion will introduce for sale two bio-like drugs applied in a cancer threatment in 2012. Founding developments took part in every BioForum edition and conceived the idea of partnership and create new biotechnology company.
BioForum 2011 Fair is the most attractive opportunity for companies from Asia to presentation in Central Europe - Siew Hwa Ong, Director and Chief Scientist, Acumen-Research (Singapur)
Based at centre of Europe, with economic and political stability, as well as a highly educated & relatively young workforce, Poland is an attractive place for biotechnology. At Lodz, biotechnology business has gained attention with the establishment of Mabion and could attract foreign companies to set up operations under the scheme of Special Economic Zone. There are also sufficient number of academic institutions that in time to come will produce more IP's to seed further biotechnology growth. This is the first time BioForum is partnering with an Asian company and the vision to bring together two clusters of biotechnology companies from the two rapidly growing markets of Central Europe and Asia. As I see that there are many synergistic similarities in these two regions (high economic growth, high human potential as well as increasing investments in R&D by both governments and private funds) as well as complementary differences (access different markets, exchange in technical know-how's), I hope these interactions would further lead to collaborations and businesses between Central European and Asian companies, leveraging one another's unique strengths.
The upcoming BioForum Fair 2011 edition Central European Business Forum of Biotechnology & Innovative BioEconomy will take place between 11th – 13th May 2011 in Lodz, Poland
